Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib. (Q39965971)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

diffuse large B-cell lymphoma

1 reference

1 reference

Jacqueline Barrientos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Y. Lynn Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

C Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P Lu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

F Y Lee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A Chadburn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J P Leonard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

F Ye

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

D Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

D M Knowles

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

3 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1755-1766

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18596745%20AND%20SRC:MED&resulttype=core&format=json

Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Rituximab therapy in malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Mechanisms of B-cell lymphoma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

B cell antigen receptor signaling 101.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Pleural Effusion in Patients With Chronic Myelogenous Leukemia Treated With Dasatinib After Imatinib Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

Optimal use of prognostic factors in non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

inferred from DOI database lookup

7 January 2021

based on heuristic

Identification and functional signature of genes regulated by structurally different ABL kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163

inferred from DOI database lookup

7 January 2021

based on heuristic

A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.163